{"news_desk": "Business", "print_page": "16", "subsection_name": null, "section_name": "Business Day", "byline": {"original": "By KATIE THOMAS", "person": [{"firstname": "Katie", "rank": 1, "lastname": "THOMAS", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1109", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "United States Politics and Government", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Trump, Donald J", "is_major": "N", "name": "persons"}, {"rank": "5", "value": "Health Insurance and Managed Care", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Biotechnology and Bioengineering", "is_major": "N", "name": "subject"}], "lead_paragraph": "Even before the president-elect vowed \u201cto bring down drug prices,\u201d many companies began taking a pre-emptive approach on pricing.", "pub_date": "2016-12-09T22:38:58+0000", "document_type": "article", "source": "The New York Times", "snippet": "Even before the president-elect vowed \u201cto bring down drug prices,\u201d many companies began taking a pre-emptive approach on pricing....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbWide.jpg"}, {"height": 412, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "412", "xlarge": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/12/09/business/10TRUMPDRUG1/10TRUMPDRUG1-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/12/09/business/donald-trump-drug-prices-pharma-stocks.html", "slideshow_credits": null, "blog": [], "_id": "584b328995d0e03926075318", "headline": {"main": "Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump", "print_headline": "Wary Drug Makers Move  to Avert Future Attacks"}}